[1] |
CDC. 2019 novel coronavirus symptoms [EB/OL].(2019-01-31) [2020-02-28]. https://www.cdc.gov/coronavirus/2019-ncov/about/symptoms.html.
|
[2] |
CHAN J F W, YUAN S F, KOK K H, et al. A familial cluster of pneumonia associated with the 2019 novel coronavirus indicating person-to-person transmission:a study of a family cluster [J]. The Lancet,2020, 395(10223): 514-523.
|
[3] |
WHO. Coronavirus disease 2019 (COVID-19): Situation report-24 [EB/OL]. (2020-02-13) [2020-02-28].https://www.who.int/emergencies/diseases/novelcoronavirus-2019/situation-reports.
|
[4] |
ROTHE C, SCHUNKM, SOTHMANN P, et al. Transmission of 2019-ncov infection from an asymptomatic contact in Germany [J]. The New England Journal of Medicine, 2020, 382: 970-971.
|
[5] |
LI Q, GUAN X H, WU P, et al. Early transmission dynamics in Wuhan, China, of novel coronavirus-infected pneumonia [J]. The New England Journal of Medicine,2020. https://doi.org/10.1056/NEJMoa2001316 (published online).
|
[6] |
WHO. Pneumonia of unknown cause-China [EB/OL].(2020-01-05) [2020-02-28]. https://www.who.int/csr/don/05-january-2020-pneumonia-of-unkown-causechina/en/.
|
[7] |
DONG N, YANG X, YE L, et al. Genomic and protein structure modelling analysis depicts the origin and infectivity of 2019-nCoV, a new coronavirus which caused a pneumonia outbreak in Wuhan, China [EB/OL]. (2020-01-22) [2020-02-28].https://doi.org/10.1101/2020.01.20.913368.
|
[8] |
LETKO M, MARZI A, MUNSTER V. Functional assessment of cell entry and receptor usage for SARS-CoV-2 and other lineage B betacoronaviruses[J]. Nature Microbiology, 2020.https://doi.org/10.1038/s41564-020-0688-y (published online).
|
[9] |
CORMAN V M, LANDT O, KAISER M, et al. Detection of 2019 novel coronavirus (2019-nCoV) by real-time RT-PCR [J]. Eurosurveillance, 2020, 25(3):2000045.
|
[10] |
BEAL J, MITCHELL T, WYSCHOGROD D,et al. Highly distinguished amino acid sequences of 2019-nCoV (Wuhan coronavirus) [EB/OL].(2020-02-02) [2020-02-28]. https://doi.org/10.1101/2020.01.31.929497.
|
[11] |
JU J, KUMAR S, LI X, et al. Nucleotide analogues as inhibitors of viral polymerases [EB/OL].(2020-01-31) [2020-02-28]. https://doi.org/10.1101/2020.01.30.927574.
|
[12] |
GUO Q, LI M, WANG C, et al. Host and infectivity prediction of Wuhan 2019 novel coronavirus using deep learning algorithm [EB/OL]. (2020-02-02) [2020-02-28]. https://doi.org/10.1101/2020.01.21.914044.
|
[13] |
ZHOU P, YANG X L, WANG X G, et al. A pneumonia outbreak associated with a new coronavirus of probable bat origin [J]. Nature, 2020, 579: 270-273.
|
[14] |
LU H. Drug treatment options for the 2019-new coronavirus (2019-nCoV) [J]. BioScience Trends, 2020,14(1): 69-71.
|
[15] |
RAMAIAH A, ARUMUGASWAMI V. Insights into cross-species evolution of novel human coronavirus 2019-nCoV and defining immune determinants for vaccine development [EB/OL]. (2020-02-04) [2020-02-28].https://doi.org/10.1101/2020.01.29.925867.
|
[16] |
QUILTY B, CLIFFORD S, FLASCHE S, et al. Effectiveness of airport screening at detecting travellers infected with 2019-nCoV [EB/OL]. (2020-02-02) [2020-02-28]. https://doi.org/10.1101/2020.01.31.20019265.
|
[17] |
ZHAO S, LIN Q, RAN J, et al. Preliminary estimation of the basic reproduction number of novel coronavirus (2019-nCoV) in China, from 2019 to 2020: A datadriven analysis in the early phase of the outbreak [J].International Journal of Infectious Diseases, 2020, 92:214-217.
|
[18] |
WU J T, LEUNG K, LEUNG G M. Nowcasting and forecasting the potential domestic and international spread of the 2019-nCoV outbreak originating in Wuhan, China: A modelling study [J]. The Lancet,2020, 395(10225): 689-697.
|
[19] |
RIOU J, ALTHAUS C L. Pattern of early human-tohuman transmission of Wuhan 2019 novel coronavirus(2019-nCoV), December 2019 to January 2020 [J]. Eurosurveillance,2020, 25(4): 2000058.
|
[20] |
READ J M, BRIDGEN J R E, CUMMINGS D A T, et al. Novel coronavirus 2019-nCoV: Early estimation of epidemiological parameters and epidemic predictions [EB/OL]. (2020-01-28) [2020-02-28].https://doi.org/10.1101/2020.01.23.20018549.
|
[21] |
MA Z E, ZHOU Y C,WANGWD, et al. Mathematical modeling and research of infectious disease dynamics[M]. Beijing: Science Press, 2004 (in Chinese).
|
[22] |
DIEKMANN O, HEESTERBEEK H, BRITTON T.Mathematical tools for understanding infectious disease dynamics [M]. Princeton: Princeton University Press, 2012.
|
[23] |
HETHCOTE H W. The mathematics of infectious diseases[J]. SIAM Review, 2000, 42(4): 599-653.
|
[24] |
KEELING M J, ROHANI P. Modeling infectious diseases in humans and animals [M]. Princeton: Princeton University Press, 2008.
|
[25] |
FUNK S, CIGLENECKI I, TIFFANY A, et al. The impact of control strategies and behavioural changes on the elimination of Ebola from Lofa County, Liberia[J]. Philosophical Transactions of the Royal Society B: Biological Sciences, 2017, 372(1721): 20160302.
|
[26] |
WANG W D, RUAN S G. Simulating the SARS outbreak in Beijing with limited data [J]. Journal of Theoretical Biology, 2004, 227(3): 369-379.
|
[27] |
GONZ′ALEZ-PARRA G, ARENAS A J, ARANDA D F, et al. Modeling the epidemic waves of AH1N1/09 influenza around the world [J]. Spatial and Spatiotemporal Epidemiology, 2011, 2(4): 219-226.
|